Meta Platforms
META
Oracle
ORCL
Strategy
MSTR
4
Toll Brothers
TOL
5
MARA Holdings
MARA
US Stock MarketDetailed Quotes
AFMD Affimed NV
- 0.960
- -0.140-12.73%
Close May 2 16:00 ET
- 0.980
- +0.020+2.08%
Post 19:13 ET
15.74MMarket Cap-0.19P/E (TTM)
1.100High0.940Low225.85KVolume1.100Open1.100Pre Close227.55KTurnover1.46%Turnover RatioLossP/E (Static)16.39MShares8.95052wk High0.81P/B14.86MFloat Cap0.52052wk Low--Dividend TTM15.48MShs Float242.000Historical High--Div YieldTTM14.55%Amplitude0.520Historical Low1.007Avg Price1Lot Size
About Affimed NV Company
Affimed NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of cancer immunotherapies. The company’s proprietary ROCK platform enables a tumor-targeted approach to recognize and kill a range of hematologic and solid tumors, enabling a broad pipeline of wholly-owned and partnered single agent and combination therapy programs. It operates through the Germany and USA geographical segments. The company was founded in 2000 and is headquartered in Mannheim, Germany.
Company Profile
SymbolAFMD
Company NameAffimed NV
Listing DateSep 12, 2014
Issue Price7.00
Founded2000
CEODr. Andreas Harstrick, M.D.
MarketNASDAQ
Employees78
Fiscal Year Ends12-31
AddressGottlieb-Daimler-Strasse 2
CityMannheim
ProvinceBaden Wuerttemberg
CountryGermany
Zip Code68165
Phone49-621-560-030
Websitehttp://www.affimed.com
Company Executives
- Name
- Position
- Salary
- Dr. Andreas Harstrick, M.D.
- Chief Medical Officer and Interim Chief Executive Officer
- 1.14M
- Denise Mueller
- Chief Business Officer; Co-President Affimed Inc.
- 1.17M
- Harry Welten
- Consulting Chief Financial Officer
- 88.00K
- Dr. Wolfgang Fischer
- Chief Operating Officer
- 1.26M
- Dr. Thomas O. Hecht
- Chairman of the Supervisory Board
- 162.00K
- Uta Kemmerich-Keil
- Member of the Supervisory Board
- 139.00K
- Dr. Ulrich M. Grau
- Member of the Supervisory Board
- 85.00K
- Dr. Mathieu Simon
- Member of the Supervisory Board
- 75.00K
- Dr. Constanze Ulmer-Eilfort
- Member of the Supervisory Board
- 39.00K
- Dr. Bernhard R.M. Ehmer
- Member of the Supervisory Board
- 78.00K
- Dr. Annalisa Mary Jenkins, F.R.C.P.,M.B.B.S.
- Member of the Supervisory Board
- 96.00K
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025